Gene · 6239
Papers2,585
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 2,585
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Non-coding regions of nuclear-DNA-encoded mitochondrial genes and intergenic sequences are targeted by autoantibodies in breast cancer. | Front Genet | 2022 | 37082114 | PubTator, text mining | PubMed |
| A Novel Tongue-Based Tumor With an RREB1-MRTFB Fusion: Variant Rhabdomyosarcoma or Aggressive Variant of Ectomesenchymal Chondromyxoid Tumor. | Cureus | 2022 | 36726902 | PubTator, text mining | PubMed |
| Fundamentals to therapeutics: Epigenetic modulation of CD8+ T Cell exhaustion in the tumor microenvironment. | Front Cell Dev Biol | 2022 | 36684449 | PubTator, text mining | PubMed |
| Genomics and Epigenomics in the Molecular Biology of Melanoma-A Prerequisite for Biomarkers Studies. | Int J Mol Sci | 2022 | 36614156 | PubTator, text mining | PubMed |
| The Role of Helicobacter pylori Neutrophil-Activating Protein in the Pathogenesis of H. pylori and Beyond: From a Virulence Factor to Therapeutic Targets and Therapeutic Agents. | Int J Mol Sci | 2022 | 36613542 | PubTator, text mining | PubMed |
| UGT2B7 c.-161C>T polymorphism frequency in Croatian population. | Arh Hig Rada Toksikol | 2022 | 36607721 | PubTator, text mining | PubMed |
| Immune system modulation in aging: Molecular mechanisms and therapeutic targets. | Front Immunol | 2022 | 36591275 | PubTator, text mining | PubMed |
| Co-segregation analysis and functional trial in vivo of candidate genes for monogenic diabetes. | BMJ Open Diabetes Res Care | 2022 | 36585034 | PubTator, text mining | PubMed |
| Dissecting the fate of Foxl2-expressing cells in fetal ovary using lineage tracing and single-cell transcriptomics. | Cell Discov | 2022 | 36575161 | PubTator, text mining | PubMed |
| The Role of Myeloid-Derived Suppressor Cells in the Treatment of Pancreatic Cancer. | Technol Cancer Res Treat | 2022 | 36573015 | PubTator, text mining | PubMed |
| Detection of a rare AXIN2 variant in an Iranian family with hypodontia and oligodontia. | J Dent Res Dent Clin Dent Prospects | 2022 | 36561383 | PubTator, text mining | PubMed |
| A comprehensive study based on exosome-related immunosuppression genes and tumor microenvironment in hepatocellular carcinoma. | BMC Cancer | 2022 | 36550445 | PubTator, text mining | PubMed |
| Combination of immune checkpoint inhibitors with radiation therapy in cancer: A hammer breaking the wall of resistance. | Front Oncol | 2022 | 36544712 | PubTator, text mining | PubMed |
| CircNTNG1 inhibits renal cell carcinoma progression via HOXA5-mediated epigenetic silencing of Slug. | Mol Cancer | 2022 | 36536414 | PubTator, text mining | PubMed |
| Genomic heterogeneity in pancreatic cancer organoids and its stability with culture. | NPJ Genom Med | 2022 | 36535941 | PubTator, text mining | PubMed |
| The relationships of OSBPL3 expression with KI-67 expression and KRAS mutations in CRC: implications for diagnosis and prognosis. | BMC Med Genomics | 2022 | 36517805 | PubTator, text mining | PubMed |
| Clinical genetics of spondylocostal dysostosis: A mini review. | Front Genet | 2022 | 36506336 | PubTator, text mining | PubMed |
| The human cytomegalovirus decathlon: Ten critical replication events provide opportunities for restriction. | Front Cell Dev Biol | 2022 | 36506089 | PubTator, text mining | PubMed |
| Intraglandular mesenchymal stem cell treatment induces changes in the salivary proteome of irradiated patients. | Commun Med (Lond) | 2022 | 36496530 | PubTator, text mining | PubMed |
| Structural transitions during the cooperative assembly of baculovirus single-stranded DNA-binding protein on ssDNA. | Nucleic Acids Res | 2022 | 36477586 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6239/papers?page=17